Wellnex Life
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 7 Aug 2026
- Reported shorts
- 9.3K
- Shares on issue
- 73.027M
Wellnex Life (WNX) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $24.8MM (source: ASX (Markit))vs $23.6MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$4.5MM (source: ASX (Markit))vs −$15.6MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.14T (source: Derived: trailing 12 months at year end)vs −$0.53T (source: Derived: trailing 12 months at year end) (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- +5.1%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of Wellnex Life Releases FY26 Annual Report, 31 Aug 2026
Wellnex Life reported FY26 revenue up 5.1% to A$24.8 million, with net loss narrowing 70.8% to A$4.5 million. No dividend was declared. The company highlighted a strategic turnaround program targeting over A$1 million in annual savings and a post-period agreement to divest the Pain Away business for up to A$21.3 million, subject to shareholder approval.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −18.3%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $24.8MM (source: ASX (Markit)) | $23.6MM (source: ASX (Markit)) | $16.9M | $27.9M |
| Gross profit | n/a | n/a | $5.1M | $4.7M |
| Operating income | n/a | n/a | −$6.5M | −$7.1M |
| EBITDA | n/a | n/a | −$11.6M | −$11.9M |
| EBIT | n/a | n/a | −$12.3M | −$12.2M |
| Interest expense | n/a | n/a | $2.4M | $1.7M |
| Pretax income | n/a | n/a | −$14.7M | −$13.8M |
| Tax | n/a | n/a | $0 | $0 |
| NPAT | −$4.5MM (source: ASX (Markit)) | −$15.6MM (source: ASX (Markit)) | −$14.7M | −$13.8M |
| Net interest income | n/a | n/a | −$2.4M | −$1.7M |
| EPS basic | −$0.14T (source: Derived: trailing 12 months at year end) | −$0.53T (source: Derived: trailing 12 months at year end) | −$0.78 | −$1.30 |
| EPS diluted | −$0.14T (source: Derived: trailing 12 months at year end) | −$0.53T (source: Derived: trailing 12 months at year end) | −$0.78 | −$1.30 |
| Shares | n/a | n/a | 28.5M | 12.2M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- FY26 Appendix 4E and Annual ReportAnnual Results31 Aug 2026via asx_announcements
- Wellnex Life Releases FY26 Annual ReportAnnual Report31 Aug 2026via asx_announcements
- Appendix 4C and Quarterly Report for Jun 2026 QuarterQuarterly Report31 Jul 2026via asx_announcements
- Appendix 4C and Quarterly Report for Mar 2026 QuarterQuarterly Report30 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results27 Feb 2026via asx_announcements
- Wellnex Life Releases Half Year ReportHalf Year Results27 Feb 2026via asx_announcements
- Appendix 4C and Quarterly Report for Dec 2025 QuarterQuarterly Report29 Jan 2026via asx_announcements
- Appendix 4C and Quarterly Report for Sep 2025 QuarterQuarterly Report20 Oct 2025via asx_announcements
- FY25 Annual ReportAnnual Report30 Sep 2025via asx_announcements
- Wellnex Life Releases FY25 Annual ReportAnnual Report30 Sep 2025via asx_announcements
Showing 10 of 28 reports